What is TLSI's P/E ratio?

TRISALUS LIFE SCIENCES INC. (TLSI) currently trades at a P/E ratio of 131.69.

TRISALUS LIFE SCIENCES INC. reports a Return on Equity (ROE) of -213.27%.

What is TLSI's dividend yield?

TRISALUS LIFE SCIENCES INC. offers a dividend yield of 0.00%.

What is TLSI's Deepscope Quality Score?

Deepscope rates TLSI's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy TLSI?

Deepscope's AI Timing Score for TLSI is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does TLSI belong to?

TRISALUS LIFE SCIENCES INC. is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.

TLSI (NASDAQ) Stock Analysis | TRISALUS LIFE SCIENCES INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

TLSI

TRISALUS LIFE SCIENCES INC.

US:NASDAQ STOCK Healthcare >> Medical Devices News 99

USD 3.17

-0.13 (-3.94%) Day Change

Watchlist Portfolio Compare Chart

131.69

P/E

2.60

D/E

-213.3%

ROE

-38.5%

ROA

0.00%

Div Yield

-18.98

PEG

TRISALUS LIFE SCIENCES INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.17 Price -0.13 (-3.94%) Day Change	NEWS SCORE: 99

TLSI, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.17
PBV / Sector	15.83 / 7.50
Earning Per Share	-0.43

PE / Sector	131.69 / 29.01
PEG or PE/Growth / Sector	-18.98 / 0.39
Average 1M Daily Value	2.29 M GREAT
Average 1W Daily Value	0.84 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-60.85 / 20.12
NPM Average (%) / Sector	-192.39 / -15.01
NPM Change Average (%) / Sector	-33.39 / 2.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-38.48 / 11.02
ROA Average (%) / Sector	-148.80 / -0.05
ROA Change Average (%) / Sector	-28.83 / 7.12
ROE (%) / Sector	-213.27 / 42.27
ROE Average (%) / Sector	126.63 / 24.22 GREAT
ROE Change Average (%) / Sector	-94.51 / 0.94
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.48
Dividend Average (%) / Sector	N/A / 1.89
Dividend Change Average (%) / Sector	N/A / 6.53

Registration Details

Analyze Date	2026-06-06 09:08:44
Symbol	TLSI
Name	TRISALUS LIFE SCIENCES INC.
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	61.42 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	202.67 / 18,389.26

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 6272 West 91st Avenue, Westminster, CO, United States, 80031

Phone: 888 321 5212

Website: https://trisaluslifesci.com

Employees: 102

Sector: Healthcare >> Medical Devices

Description: TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.